Showing results (991-1000 of 1,080) with videos related to
Sort By:
Pageof 108
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal JunctionMojun Zhu, Chunhua Chen, Nathan R Foster, et al.Stroke|December 15, 2020
Thrombus Migration and Fragmentation After Intravenous Alteplase Treatment: The INTERRSeCT StudyTomoyuki Ohara, Bijoy K Menon, Fahad S Al-Ajlan, et al.Future Oncology (London, England)|June 17, 2024
Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancerLipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, et al.Nature Chemical Biology|September 28, 2011
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90Kamalika Moulick, James H Ahn, Hongliang Zong, et al.JAMA|September 13, 2018
Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic StrokeBijoy K Menon, Fahad S Al-Ajlan, Mohamed Najm, et al.Nature Medicine|September 22, 2015
ACF chromatin-remodeling complex mediates stress-induced depressive-like behaviorHaoSheng Sun, Diane M Damez-Werno, Kimberly N Scobie, et al.JCO Precision Oncology|June 6, 2022
Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based ChemotherapyPedro Luiz Serrano Uson Junior, Umair Majeed, Jun Yin, et al.NPJ Precision Oncology|May 5, 2026
Survival outcomes with matched targeted therapy in advanced biliary tract cancer: a large global cohort analysisBinbin Zheng-Lin, Taro Shibuki, Heidi E Kosiorek, et al.Alimentary Pharmacology & Therapeutics|September 16, 2016
Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis BP Marcellin, S H Ahn, W-L Chuang, et al.Digestive Diseases and Sciences|November 13, 2021
FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic AlterationsPedro Luiz Serrano Uson Junior, Thomas T DeLeon, James M Bogenberger, et al.Pageof 108